Possible adverse drug events leading to hospital admission in a Brazilian teaching hospital

Abstract

OBJECTIVES:Drug safety problems can lead to hospital admission. In Brazil, the prevalence of hospitalization due to adverse drug events is unknown. This study aims to estimate the prevalence of hospitalization due to adverse drug events and to identify the drugs, the adverse drug events, and the risk factors associated with hospital admissions.METHOD:A cross-sectional study was performed in the internal medicine ward of a teaching hospital in São Paulo State, Brazil, from August to December 2008. All patients aged ≥18 years with a length of stay ≥24 hours were interviewed about the drugs used prior to hospital admission and their symptoms/complaints/causes of hospitalization.RESULTS:In total, 248 patients were considered eligible. The prevalence of hospitalization due to potential adverse drug events in the ward was 46.4%. Overprescribed drugs and those indicated for prophylactic treatments were frequently associated with possible adverse drug events. Frequently reported symptoms were breathlessness (15.2%), fatigue (12.3%), and chest pain (9.0%). Polypharmacy was a risk factor for the occurrence of possible adverse drug events.CONCLUSION:Possible adverse drug events led to hospitalization in a high-complexity hospital, mainly in polymedicated patients. The clinical outcomes of adverse drug events are nonspecific, which delays treatment, hinders causality analysis, and contributes to the underreporting of cases.

Incidence and Factors Associated with Drug Related Hospital Admissions in a South Indian Tertiary Care Hospital

“…Therefore, simpler pharmacotherapy should be considered by physicians to improve the clinical outcome of the patient, to decrease the rate of noncompliance with treatment due to complex dosing schedules, to contribute to safer pharmacotherapy, and to avoid the misuse and prescription of unnecessary drugs. 28 …”

Brazilian Regulation in Pharmacovigilance: A Review

“…Nowadays, not only MAH are required to monitor their products, but health care services also started to be responsible for promoting patient safety, since they evaluate all the process of drug use (the need, safety, effectiveness, and adherence). This allows to analyze the profile of drug use, risk factors for the occurrence of ADEs [15], and problems related to ineffectiveness, such as polymorphisms [16], drug quality deviations and medication errors [17,18].…”

Polifarmacy And The Compliance of Geriatric With Chronic Disease

“…Dalam penelitian ini analisis risiko pemberian obat polifarmasi (> 5 item obat) dan tingkat kepatuhan dilakukan dengan melakukan uji statistik menggunakan chi square, dan didapatkan hasil polifarmasi tidak berhubungan secara signifikan terhadap tingkat kepatuhan (p > 0,05). Varallo et al (2014) menyatakan bahwa polfarmasi dapat meningkatkan masalah kepatuhan sebanyak 14%.…”